-
1
The study enrolled more than 3,200 current smokers referred for low-dose CT lung cancer screening at US medical centers.
-
2
Participants were assigned to 1 of 4 strategies combining usual care, free cessation medications, financial incentives, and the FutureMe text-based tool.
-
3
At 6 months, blood-test-verified quit rates were 3% with usual care, 1% with free medications, 8% with medications and incentives, and 2% with all interventions.
-
4
The highest quit rate occurred among participants offered free medications and financial incentives of up to $600.
-
5
The study authors are planning additional trials to assess how financial incentive-based cessation programs can be implemented more broadly.
